Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of a vaccination targeting HPV16-related cancers in head and neck, cervical, and anal cancers…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]
Phase 3 trial evaluating the addition of Triapine to cisplatin-based chemoradiation for cervical and vaginal cancers; results were posted in…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]
Phase 3 trial update evaluating adding Triapine to cisplatin-based chemoradiation for advanced cervical and vaginal cancers is in active not…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer [Phase 3]
A Phase 3 trial evaluating induction chemotherapy with immunotherapy followed by concurrent chemoradiation in advanced cervical cancer is cu…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy [Phase 2]
Phase II clinical study evaluating IBI310 or placebo with sintilimab for advanced cervical cancer after failure or intolerance to platinum-b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer [Phase 2]
Phase 2 trial updates the combination of VB10.16 (Nykode) and atezolizumab in HPV-16 positive cervical cancer; study status is completed.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 9-valent HPV recombinant vaccine in Chinese healthy females has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a combination immunotherapy regimen in adults with advanced HPV-associated cancers.…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial evaluating adding cetuximab to chemotherapy for advanced or recurrent cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) [Phase 3]
Phase 3 trial KEYNOTE-826 evaluating pembrolizumab plus chemotherapy vs placebo plus chemotherapy in first-line cervical cancer; results dem…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Rural Interventions for Screening Effectiveness [NA]
Completed clinical trial evaluating rural interventions to improve screening effectiveness for breast, cervical, or colorectal cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread [Phase 3]
A Phase 3 trial evaluating induction chemotherapy followed by standard therapy for cervical cancer with aortic lymph node involvement is cur…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy [Phase 3]
Phase 3 trial investigating radical surgery with or without adjuvant radiotherapy for intermediate-risk cervical cancer is currently recruit…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer [Phase 2]
Phase 2 trial update evaluating PEG-rhG-CSF to prevent neutropenia during concurrent chemoradiotherapy for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial [NA]
A clinical trial update examining self-testing options in the era of primary HPV screening for cervical cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial evaluating a quadrivalent HPV recombinant vaccine in Chinese healthy females was terminated.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer [Phase 1]
This Phase 1 trial evaluates atezolizumab given before and/or with chemoradiotherapy in node-positive stage IB2, II, IIIB, or IVA cervical c…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) [Phase 1, Phase 2]
Phase 1/2 trial update for a therapy in cervical cancer and expansion into select solid tumors; study status completed.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study） [Phase 4]
Phase 4 clinical trial update for the CITRUS study assessing HPV testing intervention for cervical cancer screening. Completed status.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age [Phase 3]
A Phase 3 trial comparing immunogenicity of a recombinant HPV nonavalent vaccine against Gardasil 9 in healthy women aged 18-26 has complete…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial update evaluating caldonirimab plus nimotuzumab for recurrent or metastatic cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer [Phase 2]
Phase 2 trial update for bintrafusp alfa monotherapy in platinum-experienced cervical cancer (uterine cervical neoplasms) with completed sta…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Smoking Cessation for Cervical Cancer Survivors [NA]
Completed clinical trial on smoking cessation interventions for cervical cancer survivors; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update evaluating SHR-1210 in combination with apatinib for metastatic, persistent, or recurrent cervical cancer has …